Nitric oxide and pulmonary circulation

Medical Science Monitor

Volumn 8, Issue 8, 2002, Pages

  Clini, Enrico ^a   Ambrosino, Nicolino ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

COPD; Hypoxia; Pulmonary hypertension

Indexed keywords

N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; EXERCISE; GAS EXCHANGE; HEART FAILURE; HUMAN; HYPOXIA; LUNG ARTERY; LUNG BLOOD FLOW; LUNG VASCULAR RESISTANCE; NONHUMAN; PATHOPHYSIOLOGY; PULMONARY HYPERTENSION; SHEAR STRESS; SYSTEMIC SCLEROSIS; ANIMAL; BREATH ANALYSIS; LUNG CIRCULATION; METABOLISM; PHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

ANIMAL; BREATH TESTS; ENDOTHELIUM, VASCULAR; HUMAN; HYPERTENSION, PULMONARY; NITRIC OXIDE; PULMONARY CIRCULATION; ANIMALS; HUMANS;

EID: 0036687551     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
2. The role of endothelium in the responses of vascular smooth muscle to drugs
3. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide
4. Nitric oxide: Physiology, pathophysiology and pharmacology
5. Pulmonary hypertension. Anatomic and physiologic correlates
6. Nitric oxide and control of pulmonary vascular resistance
7. Observations on the pulmonary arterial blood pressure in the cat
8. Effect of alveolar hypoxia on pulmonary vascular resistance
9. Effect of lung inflation and hypoxia on pulmonary arterial blood volume
10. Tolbutamide reverses hypoxic pulmonary vasoconstriction in isolated rat lungs
11. Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction
12. Acetylcholine and bradykinin relax intrapulmonary arteries by acting on endothelial cells: Role in vascular disease
13. Endothelium-dependent relaxation of human pulmonary arteries
14. NW-nitro-L-arginine methyl ester selectively inhibits pulmonary vasodilator responses to acetylcholine and bradykinin
15. Antagonists of EDRF attenuate acetyl-choline induced vasodilation in isolated hamster lungs
16. A comparison of the pharmacological and mechanical properties in vitro of large and small pulmonary arteries of the rat
17. Immunological detection of nitric oxide synthase(s) in human tissues using heterologous antibodies suggesting different isoforms
18. Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans
19. Endogenous endotheliumderived relaxing factor opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in anesthetized rabbits
20. Nature and site of action of endogenous nitric oxide in the vasculature of isolated pig lungs
21. Flow-induced release of EDRF in the pulmonary vasculature: Site of release and action
22. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease
23. Endothelial dysfunction in pulmonary arteries of patients with mild COPD
24. Basal and stimulated release of pulmonary endothelial nitric oxide from isolated human lungs
25. Effects of chronic hypoxia and altered hemodynamics on endothelial nitric oxide synthase expression in the adult rat lung
26. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans
27. Measurement of exhaled nitric oxide in humans and animals
28. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide
29. Clinical aspects of exhaled nitric oxide
30. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children
31. Modeling the production of nitric oxide within the human airways
32. Mixed expired nitric oxide in primary pulmonary hypertension in relation to lung diffusion capacity
33. Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension
34. Exhaled nitric oxide and pulmonary response to iloprost in systemic sclerosis with pulmonary hypertension
35. Decreased basal production of nitric oxide in patients with heart disease
36. Endogenous nitric oxide in patients with chronic heart failure (CHF): Relation to functional impairment and nitrate-containing therapies
37. Exhaled nitric oxide during exercise in primary pulmonary hypertension and pulmonary fibrosis
38. Increased nitric oxide in exhaled air of patients with systemic lupus erythematosus
39. Abluminal release and asymmetrical response of the rabbit arterial wall to endothelium-derived relaxing factor
40. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension
41. Endogenous nitric oxide in patients with stable COPD: Correlates with severity of disease
42. Production of endogenous nitric oxide in chronic obstructive pulmonary disease and patients with cor pulmonade. Correlates with echo-Doppler assessment
43. A two-compartment model of pulmonary nitric oxide exchange dynamics
44. Single-exhalation profiles of NO and CO2 in humans: Effect of dynamically changing flow rate
45. Determination of production of nitric oxide by lower airways of humans - Theory
46. EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs
47. Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome
48. Exhaled nitric oxide in isolated pig lungs
49. Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism
50. Continuous inhalation of nitric oxide protects against the development of pulmonary hypertension in chronically hypoxic rats
51. Chronic inhaled nitric oxide: Effects on pulmonary vascular endothelial function and pathology in rats
52. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium
53. Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats
54. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats